BIOMAT Database Logo BIOMAT Database Logo

Oral candidiasis in HIV-infected patients and its relation to CD4 + counts: an adjunct clinical marker of HIV disease progression. 2006

Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002180 Candidiasis, Oral Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed) Moniliasis, Oral,Thrush,Candidiases, Oral,Moniliases, Oral,Oral Candidiases,Oral Candidiasis,Oral Moniliases,Oral Moniliasis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
CD4 lymphocyte percentage vs CD4 lymphocyte count as an immunological marker of oral candidiasis in HIV-infected patients.
May 2001, Oral diseases,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
January 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
CD4 cell counts and oral manifestations in HIV infected and AIDS patients.
January 2018, Journal of oral and maxillofacial pathology : JOMFP,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Immunological characteristics of HIV-infected children: relationship to age, CD4 counts, disease progression, and survival.
October 1995, AIDS research and human retroviruses,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Progression to AIDS in HIV-infected patients with oral candidiasis or hairy leukoplakia.
July 1992, AIDS (London, England),
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Oral candidiasis in HIV-infected patients.
January 1995, Current topics in medical mycology,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Oral candidiasis as a marker of HIV disease progression among Zimbabwean women.
April 2008, Journal of acquired immune deficiency syndromes (1999),
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients.
January 2019, Frontiers in dentistry,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
June 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Ekta Gupta, and Madhu Vajpayee, and Immaculata Xess, and Pradeep Seth
[Oral manifestations of candidiasis in HIV-infected patients. Clinical and microbiological studies].
January 1988, Deutsche Zeitschrift fur Mund-, Kiefer- und Gesichts-Chirurgie,
Copied contents to your clipboard!